CMS Reverses 340B Drug Pricing Program Rate Cuts
Centers for Medicare and Medicaid Services CMS announced that it expects to reverse Medicare Part B rate cuts for separately payable drugs acquired through 340B Drug Pricing Program, resulting in estimated additional $1.96 billion for 340B hospitals.